Back to Blog

Hydrosalpinx Treatment and Infertility

Dr. Senai Aksoy · · 14 min read
Medically reviewed on 3 September 2026 - Dr. Senai Aksoy
A serene woman resting thoughtfully near a sunlit window — editorial photography for hydrosalpinx and fertility article

Key Takeaways

Hydrosalpinx means a damaged fallopian tube is blocked and filled with fluid. That fluid can lower natural fertility and reduce embryo implantation in IVF if it reaches the uterine cavity. Diagnosis and treatment — often salpingectomy or proximal tubal occlusion — usually come before the next embryo transfer.

Key evidence: ASRM — tubal surgery in the ART era (2021) Cochrane review — surgical treatment for tubal disease before IVF WHO — guideline on tubal disease and infertility (2025)

On this page

Why this diagnosis changes the IVF timeline

If a hydrosalpinx communicates with the uterine cavity, treatment is usually discussed before embryo transfer. First, the team needs to confirm the finding and decide which approach suits your circumstances.

Hydrosalpinx is a fallopian tube that has become blocked and swollen with fluid. It may first appear on an ultrasound or hysterosalpingogram (HSG) during a fertility assessment, even when you have no pain. The finding can change the plan for your next embryo transfer.

A damaged tube can make natural conception harder. If its fluid reaches the uterine cavity, it may also reduce the chance of implantation after in vitro fertilisation (IVF). The ASRM committee opinion describes poorer IVF outcomes with untreated hydrosalpinx; this does not mean that every transfer will fail.

The 1999 Scandinavian randomised trial supports salpingectomy before IVF in women with hydrosalpinx. The 2020 Cochrane review found a probable improvement in clinical pregnancy after salpingectomy compared with no surgery, but no live-birth data for that main comparison. Clinical pregnancy and live birth are different outcomes, and treatment cannot promise either.

Hydrosalpinx usually develops after pelvic infection, inflammation, surgery or endometriosis. Many women first hear the term during an infertility assessment — often with little or no pelvic pain beforehand.

If IVF is planned, discuss the tube before arranging embryo transfer. Surgery and egg collection do not always follow the same order. If you are travelling for care, allow time for this assessment in your IVF in Turkey or IVF abroad plans.

What is hydrosalpinx?

A hydrosalpinx develops when the far end of a fallopian tube closes and fluid collects inside, stretching the tube.

A healthy fallopian tube picks up the egg, facilitates fertilisation between egg and sperm, and transports the early embryo towards the uterus. When the far end seals shut, fluid collects inside. The tube swells.

Imaging may show a swollen, elongated tube beside the ovary. Fluid near an ovary alone does not establish the diagnosis: the clinician needs to identify where the fluid is and whether the tube is enlarged.

One tube or both may be affected. When both are involved, natural pregnancy becomes exceptionally unlikely without medical intervention.

Why hydrosalpinx affects fertility

The blocked tube can prevent egg and sperm from meeting. If the tube still communicates with the uterus, its fluid may reach the cavity and interfere with implantation.

The ASRM review discusses several possible explanations, including changes in how the uterine lining receives an embryo, movement of fluid through the cavity and direct effects on embryos. How much each mechanism contributes in humans remains uncertain.

Tubal damage also increases the risk of ectopic pregnancy, where a pregnancy develops outside the uterus. If you conceive after tubal disease or surgery, discuss early follow-up to confirm the pregnancy’s location with your clinician.

Symptoms: sometimes absent, sometimes noticeable

Hydrosalpinx may cause no noticeable symptoms. Feeling well does not rule it out.

When symptoms do appear, they may include intermittent pelvic ache, unusual watery vaginal discharge, discomfort during intercourse, or difficulty conceiving.

Checking whether the tubes are open is part of a thorough fertility assessment.

Common causes

Previous pelvic infection, endometriosis and scarring after surgery can damage the tube. Not everyone remembers an illness before the diagnosis.

Common causes and relevant medical history include:

Sometimes no single past event comes to mind. The damage can still show clearly on a hysterosalpingogram or at laparoscopy.

How doctors diagnose hydrosalpinx

HSG and transvaginal ultrasound provide different information about the tubes. Laparoscopy is not a routine first test; it may be useful when there is a separate reason for surgery (ASRM guidance).

Hysterosalpingography (HSG) uses contrast visible on X-rays to check whether it fills the tubes and spills from their ends into the pelvic cavity. A hydrosalpinx typically appears as a dilated tube with no peritoneal spill. An HSG remains the most common first test to evaluate tubal patency.

Transvaginal ultrasound may show an elongated, fluid-filled cystic structure beside the ovary with incomplete septa. However, an ultrasound showing no visible abnormality does not definitively exclude an intermittently draining hydrosalpinx.

Laparoscopy is keyhole surgery that lets the surgeon inspect the pelvis directly. It may be considered when findings need clarification and the result would change treatment, or when surgery is already planned. An uncertain scan does not automatically mean you need an operation.

Bring prior HSG films (DICOM files) or operative notes if you have them. An international clinic can review the original images and avoid repeating tests unnecessarily.

Hydrosalpinx treatment options

For hydrosalpinx before IVF, WHO’s 2025 guideline suggests salpingectomy or tubal occlusion. This is a conditional recommendation based on very low-certainty evidence. The choice depends on anatomy, adhesions, surgical feasibility and your preferences.

The plan depends on whether pregnancy is sought naturally or through IVF, whether one or both tubes are diseased, pelvic pain, and ovarian reserve considerations (WHO guideline).

Salpingectomy

Salpingectomy removes the affected tube, usually by laparoscopy. It removes that source of fluid, but it is irreversible. The surgeon must consider adhesions and protect the ovarian blood supply (WHO guidance).

Proximal tubal occlusion

The tube is coagulated or clipped near the uterus, disconnecting the tube from the uterine cavity. This prevents fluid from entering the womb while leaving the distal tube in place. It is chosen when extensive adhesions or low ovarian reserve make dissection near the ovarian blood supply less desirable.

Salpingostomy or drainage

These are different procedures. Salpingostomy creates an opening at the far end of the tube and may suit selected women with mild damage who want to try for natural pregnancy. Re-blockage and ectopic pregnancy remain risks (ASRM guidance).

Needle aspiration temporarily removes the fluid. It may collect again. WHO prefers salpingectomy or occlusion before IVF, but allows aspiration when neither operation is available or feasible.

Choosing among options

Before surgery or transfer is scheduled, these questions need clear answers:

These answers help you and the team agree on a plan before transfer, rather than treating an imaging report in isolation.

Dr Aksoy’s clinical perspective

“Before IVF, if imaging shows a true hydrosalpinx that communicates with the uterine cavity, my aim is simple: stop that fluid reaching the cavity. I tell patients the goal is not necessarily to remove the tube. It is to protect the space where the embryo will implant.

“When removal looks safe and ovarian blood supply can be preserved, I prefer laparoscopic salpingectomy. The diseased tube is gone. We do not leave a sealed segment that can refill. I put it this way: taking out a tube that does not work and that carries fluid into the uterus is not about reducing your chance of pregnancy. It is about protecting the environment where an embryo has to settle.

“I consider proximal occlusion more readily when the tube is firmly attached by adhesions to the ovary or pelvic sidewall, when prior infection, endometriosis, or surgery has distorted the anatomy, or when safe removal would mean a wide dissection near the ovarian hilum. I also consider this approach for patients with a single ovary, a low AMH level, a low antral follicle count or a previous poor response to stimulation. Surgery on both tubes may raise additional concerns about ovarian blood flow.

“Ovarian reserve cannot be judged from an AMH level alone. What the tube looks like at surgery — how stuck it is to the ovary, whether a safe tissue plane exists — often matters more. Low ovarian reserve does not automatically rule out salpingectomy. But if removing the tube means risking the ovarian vessels, occlusion can be the wiser protective choice.

“Distal drainage or fenestration may also be planned with occlusion, so the remaining segment is less likely to over-distend or become a focus of infection. Both approaches are accepted before IVF. The choice depends on anatomy, adhesions, surgical judgement and ovarian reserve — in line with ASRM and WHO guidance.

“Unilateral disease with a genuinely open, healthy opposite tube does not make natural pregnancy impossible — especially if the patient is younger, ovarian reserve is good and semen analysis is normal. ‘The other tube is open’ is not enough on its own. Tube size and wall quality, pain or infection history, and adhesions around the opposite tube still matter.

“For patients under 35 with good ovarian reserve and no other major factor, I may suggest about six months of trying naturally after surgery, or six to twelve months in selected cases. For patients aged 35 to 37, I usually limit this period to three to six months. For patients aged 38 or over, or those with low ovarian reserve, a long history of infertility or a male factor, I consider IVF earlier.

“Severe bilateral damage, a prior ectopic pregnancy, or another clear fertility problem can also make a long natural wait inappropriate. I explain that an open opposite tube means natural conception may still be possible. If age limits the time available, we need to weigh further natural attempts against moving to IVF.

“I rarely consider needle drainage alone a long-term solution. Fluid often comes back. A scan showing no fluid on transfer day does not mean the problem is solved. It may be discussed only as a temporary option when surgery is not feasible.

“I consider salpingostomy in a few specific circumstances: the patient is younger and wants to conceive naturally, has no other major infertility factor, and has a mild distal hydrosalpinx with a thin wall and relatively well-preserved inner lining and fimbriae. An experienced tubal surgeon also needs to be available. Opening a tube does not turn it into a normal tube.

“Re-occlusion and ectopic pregnancy remain risks. I do not favour salpingostomy followed by months of waiting when the tube has a thick wall, is markedly enlarged, has a damaged inner lining or is surrounded by dense adhesions.

“After uncomplicated laparoscopic salpingectomy or occlusion I usually find one menstrual cycle — about four to six weeks — enough, after reviewing recovery and checking for abnormal pelvic fluid, haematoma, or persistent fluid reaching the uterine cavity. More extensive surgery, infection, the release of dense adhesions or an additional procedure for endometriosis may extend the recovery period to two or three months. I have no fixed three-month rule.

“If hydrosalpinx is found during stimulation, I prefer not to do a fresh transfer. Collect the eggs, freeze the embryos, treat the tube, then transfer when the cavity is safer. With low reserve or advanced age, I may reverse the order — stimulate and freeze first, then perform surgery, then transfer the frozen embryos — so age-related loss during recovery is limited. Egg collection can precede surgery. Embryo transfer should not go ahead while a communicating hydrosalpinx is still untreated.

“An ultrasound showing no visible abnormality does not rule out hydrosalpinx. The tube is not always fluid-filled at the moment of scanning. Spasm, technical limitations or misinterpretation of the images can also make HSG findings misleading. I do not operate on a written phrase alone. ‘May be compatible with hydrosalpinx’ is not a surgical indication. I need to see whether the tube is truly dilated and whether contrast spills into the abdomen.

“For international patients I ask for the original DICOM files or a high-quality series of HSG images, the procedure report, prior ultrasound and operative notes, and laparoscopy images when they exist. Clear images showing typical findings do not automatically require a repeat HSG simply because they were taken in another country. If the images are incomplete or of poor quality, only a report is available, or the ultrasound and HSG findings disagree, I arrange a transvaginal ultrasound assessment by an experienced clinician.

“HSG or HyCoSy can then be repeated if needed. I will not base irreversible surgery before transfer on an ambiguous report.

“Where surgery happens depends on surgical quality, not on the patient’s passport. If the diagnosis is clear, the procedure is straightforward, and an experienced laparoscopic surgeon is available locally, surgery at home can be fine — with an operative report identifying the procedure and the tube treated, photographs or video when available, and a pathology report when relevant.

“I prefer to coordinate surgery in Istanbul with the team planning the transfer if the diagnosis is uncertain, dense adhesions or deep endometriosis are expected, or protection of the ovarian vessels is a major concern. This also applies when the choice between salpingectomy and occlusion can only be made during laparoscopy. Coordination may be needed if the timing of embryo freezing and surgery is complex, or if local expertise in tubal surgery that preserves fertility is uncertain.

“My summary line: before IVF, the aim with hydrosalpinx is not the largest possible operation. It is to prevent hydrosalpinx fluid from reaching the uterine cavity while protecting ovarian blood supply and making careful use of the time available for treatment. Salpingectomy is first choice in most suitable cases. When the anatomy is difficult or there are concerns about ovarian reserve, proximal occlusion is not a second-class option — it is a deliberate protective alternative.”

IVF after hydrosalpinx treatment

Recovery and transfer timing are individual. The four-to-six-week interval in Dr Aksoy’s account above describes his approach after uncomplicated surgery, not a universal deadline. The age bands and waiting periods in that account are also clinical decision guides, not mandatory thresholds.

  1. Confirm the diagnosis using the images and relevant medical records.
  2. Discuss the surgical options and whether egg collection should come first.
  3. Allow recovery and review any ongoing symptoms or abnormal findings with the team.
  4. Schedule embryo transfer once the team has reassessed the uterine cavity and the effect of the treated tube.

WHO identifies the best timing of surgery relative to stimulation and egg collection as an evidence gap. Treatment can address one factor affecting IVF; age, egg and sperm factors, embryo development and other uterine conditions still matter. For previous unsuccessful cycles, see what to review before the next IVF attempt.

FAQ

Can someone still get pregnant naturally with hydrosalpinx?

Sometimes, particularly if the opposite tube is healthy and open. Age, ovarian reserve, infertility duration and semen analysis help guide whether and how long to try naturally. Because tubal disease increases ectopic pregnancy risk, agree on early pregnancy follow-up with your clinician.

Why do fertility specialists recommend surgery before IVF?

Fluid from a communicating hydrosalpinx may interfere with implantation. Surgery aims to stop it reaching the uterus. Evidence supports an improvement in clinical pregnancy, but an individual live-birth outcome cannot be guaranteed.

Is draining the fluid enough?

It may provide temporary relief, but fluid can return. WHO favours salpingectomy or occlusion before IVF when feasible; aspiration remains an option when those procedures cannot be offered.

Does hydrosalpinx always cause pelvic pain or discharge?

No. Many women have neither symptom. The condition is frequently an incidental finding during standard fertility evaluations.

Is “liquid in the fallopian tube” the same as hydrosalpinx?

It can be, if the fluid is inside a blocked, enlarged tube. A report mentioning fluid beside the ovary or a cyst is not enough on its own. The actual images help distinguish these findings.

How is hydrosalpinx confirmed?

HSG and transvaginal ultrasound are common first investigations. Laparoscopy may confirm and treat tubal disease when there is an indication for surgery; it is not required for every diagnosis.

Should both tubes be removed if only one shows hydrosalpinx?

Not automatically. If the contralateral tube is structurally normal, healthy, and patent, it can be preserved — especially if natural conception remains a personal goal.

Sources

Next step

A question about your own case?

An article can set out the general picture, but not what applies to your own history. If you would like your situation looked at, you can send your questions and any previous reports to the medical team.

For privacy, please send only information needed for an initial reply. Ask the team which secure channel to use for medical reports or identity documents.

Request a medical review

Add as a Preferred Source on Google

You can add draksoyivf.com as one of your preferred health information sources on Google.

Add on Google
Dr. Senai Aksoy

Dr. Senai Aksoy studied and trained in France before returning to Turkey, where he was a member of the ICSI team at Sevgi Hospital, Ankara — the country's first ICSI centre (1994-95) — and a co-author on the first Turkish ICSI publications produced in collaboration with the Brussels Van Steirteghem group (Human Reproduction, 1996; PMID 8671323). He helped build the IVF programme at the American Hospital Istanbul and has been running his own fertility practice since 1998.

Verified profiles: PubMed ORCID LinkedIn

Instagram YouTube

The content has been created by Dr. Senai Aksoy and medically approved.

Privacy and measurement choices

Necessary storage keeps the site working. If you accept, Google Analytics and Microsoft Clarity may use optional cookies to help us understand site use and measure advertising. Personalized advertising remains off. If you decline, optional cookies stay off; Google Consent Mode may still send limited, cookieless measurement signals. You can change your choice later.

Privacy policy